Karyopharm Therapeutics Inc. (KPTI) Return on equity 2016–2020
Karyopharm Therapeutics Inc. (KPTI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-388.3%FY2020 · since FY2016: -67.5% → -388.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -388.3% | +12.7 pp |
| FY2019 | -401.0% | -303.6 pp |
| FY2018 | -97.4% | +2.2 pp |
| FY2017 | -99.6% | -32.1 pp |
| FY2016 | -67.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice